Uterolysis: Physiology of Uterine Relaxation in Pregnancy and Labor

Uterolysis refers to the physiologic relaxation and softening of uterine smooth muscle and connective tissue, primarily mediated by the hormone relaxin (from corpus luteum, placenta, decidua).

Key Mediators

  • Relaxin – Remodels collagen, increases cervical compliance, inhibits myometrial contractility.
  • Progesterone – Maintains quiescence via genomic and non-genomic pathways.
  • Estrogen – Upregulates contraction-associated proteins (CAPs) near term, opposing uterolysis.
  • Prostaglandins – Promote cervical ripening and contractility; balance shifts at labor onset.
  • Nitric oxide, β-adrenergic agonists – Acute tocolytic pathways.

Phases

  1. Throughout pregnancy – Uterolysis accommodates fetal growth; prevents preterm labor.
  2. Cervical ripening (pre-labor) – Collagen breakdown, glycosaminoglycan increase.
  3. Active labor – Uterolysis gives way to coordinated contractions (uterotonic shift).
  4. Postpartum – Involution requires renewed contractility; failure → uterine atony, hemorrhage.

Clinical Relevance

Excessive uterolysis (e.g., relaxin excess, tocolytic overdose) → uterine atony → postpartum hemorrhage. Insufficient uterolysis → preterm labor, cervical insufficiency. Tocolytics (magnesium, nifedipine, indomethacin) pharmacologically enhance uterolysis to arrest preterm labor.

Urinary Disorders - Related Articles